Trial of Pentoxifylline in Patients With Functional Disability Caused by Radiation-Induced Advanced Regional Fibrosis
Status:
Completed
Trial end date:
2000-03-01
Target enrollment:
Participant gender:
Summary
After initial assessment of their condition by specified clinical and laboratory parameters,
each of the patients will be treated for 8 weeks at the standard pentoxifylline dose (400 mg
po TID). Objective and subjective response parameters will be re-assessed at the end of the
treatment and 8 weeks later for possible decay of response.